Skip to Main Content

Paper Details

A unique type of GSK-3 inhibitor brings new opportunities to the clinic.
Sci Signal
51
2016
AD, Alzheimer's disease, GSK-3, Glycogen synthase kinase-3, L807mts, adenosine triphosphate, central nervous system disorders, mouse, neurodegenerative disorders, patients
Author NameAffiliation
Miriam EisensteinWeizmann Institute of Science
Miriam EisensteinWeizmann Institute of Science
  • 1 - 2

Datasets

Release 1.2